Association of various patient parameters including procedural and postprocedural events and thrombus length (mm)
| N (122) | Average clot length (mm) | p Value | |
|---|---|---|---|
| Recanalization time, min | 118 | 0.36 | |
| 0–60 | 47 | 14.1 (10.9) | |
| >60 | 71 | 12.4 (8.4) | |
| Treatment | 122 | ||
| IV tPA | 14 | 15.4 (17.0) | |
| IA tPA | 61 | 14.1 (8.8) | |
| IV + IA tPA | 34 | 12.1 (6.7) | |
| No IV or IA tPA | 13 | 10.8 (7.7) | |
| mRS at 90 days | 112 | ||
| 0 | 14 | 12.2 (6.6) | |
| 1 | 26 | 11.8 (7.1) | |
| 2 | 13 | 15.2 (9.8) | |
| 3 | 14 | 13.5 (7.6) | |
| 4 | 13 | 11.7 (9.0) | |
| 5 | 5 | 16.8 (10.1) | |
| 6 | 27 | 16.3 (13.7) | |
| mRS at 90 days categorized as good outcome | 112 | 0.30 | |
| mRS 0–2 | 53 | 12.8 (7.7) | |
| mRS>2 | 59 | 14.6 (11.2) | |
| mRS at 90 days categorized as bad outcome | 112 | 0.15 | |
| mRS 5–6 | 32 | 16.3 (13.1) | |
| mRS<5 | 80 | 12.7 (7.8) | |
| Post TICI flow | 122 | ||
| 0 | 7 | 16.4 (9.8) | |
| 1 | 4 | 16.3 (8.8) | |
| 2A | 16 | 11.5 (6.1) | |
| 2B | 50 | 14.0 (11.9) | |
| 3 | 45 | 12.4 (7.3) | |
| Post TICI flow categorized as good flow | 122 | 0.92 | |
| 0–2A | 27 | 13.5 (7.6) | |
| 2B–3 | 95 | 13.3 (10.0) | |
| Clinically significant event | 119 | 0.13 | |
| Yes | 4 | 6.3 (3.6) | |
| No | 115 | 13.5 (9.5) | |
| Procedural complications | 122 | 0.11 | |
| Yes | 10 | 8.7 (6.6) | |
| No | 112 | 13.7 (9.6) | |
| Hemorrhage | 122 | 0.66 | |
| Yes | 19 | 14.2 (7.6) | |
| No | 103 | 13.2 (9.8) | |
| Hyperdense MCA | 122 | 0.009 | |
| Yes | 75 | 15.2 (7.9) | |
| No | 47 | 10.3 (10.9) |
Data are expressed as mean (SD).
IA, intra-arterial; IV, intravenous; MCA, middle cerebral artery; mRS, modified Rankin Scale; TICI, Thrombolysis In Cerebral Ischemia; tPA, tissue plasminogen activator.